BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20202147)

  • 1. Effect of inhaled steroid and montelukast on clinical symptoms in children with newly diagnosed asthma: a pilot study.
    Olszowiec-Chlebna M; Majak P; Brzozowska A; Bobrowska-Korzeniowska M; Jerzynska J; Stelmach I
    Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e687-90. PubMed ID: 20202147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma.
    Stelmach I; Bobrowska-Korzeniowska M; Majak P; Stelmach W; Kuna P
    Pulm Pharmacol Ther; 2005; 18(5):374-80. PubMed ID: 15939317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study.
    Stelmach I; Majak P; Jerzynska J; Stelmach W; Kuna P
    Pediatr Allergy Immunol; 2004 Aug; 15(4):359-64. PubMed ID: 15305946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
    Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
    Kopriva F; Dzubak P; Potesil J; Hajduch M
    J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year.
    Weiss KB; Gern JE; Johnston NW; Sears MR; Jones CA; Jia G; Watkins MW; Smugar SS; Edelman JM; Grant EN
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):174-81. PubMed ID: 20674830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
    Simons FE; Villa JR; Lee BW; Teper AM; Lyttle B; Aristizabal G; Laessig W; Schuster A; Perez-Frias J; Sekerel BE; Menten J; Leff JA
    J Pediatr; 2001 May; 138(5):694-8. PubMed ID: 11343045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
    Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
    J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
    Barnes N; Laviolette M; Allen D; Flood-Page P; Hargreave F; Corris P; O'Connor B; Tate H; Parker D; Pavord I
    Respir Med; 2007 Aug; 101(8):1652-8. PubMed ID: 17481879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma.
    Majak P; Rychlik B; Pułaski L; Błauz A; Agnieszka B; Bobrowska-Korzeniowska M; Kuna P; Stelmach I
    J Allergy Clin Immunol; 2010 Jun; 125(6):1220-7. PubMed ID: 20434204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial.
    Price DB; Swern A; Tozzi CA; Philip G; Polos P
    Allergy; 2006 Jun; 61(6):737-42. PubMed ID: 16677244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens.
    Peroni D; Bodini A; Miraglia Del Giudice M; Loiacono A; Baraldi E; Boner AL; Piacentini G
    Allergy; 2005 Feb; 60(2):206-10. PubMed ID: 15647042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
    Buchvald F; Bisgaard H
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
    Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
    Luskin A; Bukstein D; Kocevar VS; Yin DD
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.